查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1668094

客製化基因合成​​服务市场 - 全球产业规模、份额、趋势、机会和预测，按类型、应用、地区和竞争细分，2020-2030 年

Custom Gene Synthesis Service Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Application, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024 年全球客製化基因合成​​服务市值为 15.4 亿美元，预计到 2030 年将达到 25.2 亿美元，预测期内的复合年增长率为 8.54%。这个市场已经成为生命科学和生物技术产业中一个充满活力且快速发展的领域。客製化基因合成​​服务涉及人工创建 DNA 序列，使研究人员和生物技术公司能够设计和获取用于各种应用的客製化遗传物质。

市场概况
预测期 2026-2030
2024 年市场规模 15.4 亿美元
2030 年市场规模 25.2 亿美元
2025-2030 年复合年增长率 8.54％
成长最快的领域 商业的
最大的市场 北美洲

近年来，由于基因治疗、合成生物学、疫苗开发和基因工程等领域对合成 DNA 构建体的需求不断增加，市场经历了显着增长。个人化医疗和标靶治疗的兴起是主要驱动因素之一。客製化设计的 DNA 序列对于开发旨在在分子层面上治疗遗传疾病的基因疗法至关重要。此外，合成生物学的扩展为设计和改造生物系统创造了新的机会，进一步增加了对合成 DNA 的需求。

技术进步，特别是固相合成等基因合成方法的进步，提高了 DNA 合成的准确性和效率，推动了市场成长。基因合成成本的降低，加上服务提供者数量的不断增加，使得各种规模的研究人员和组织可以更轻鬆地进行客製化基因合成​​。

主要市场驱动因素

主要市场挑战

主要市场趋势

目录

第 1 章：产品概述

第 2 章：研究方法

第 3 章：执行摘要

第 4 章：顾客之声

第五章：全球客製化基因合成​​服务市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 依类型（1000 bp 以下、1001 至 3000 bp、3001 至 5000 bp、5000 bp 以上）
    • 按应用（商业、学术研究）
    • 按地区
    • 按公司分类（2024）
  • 市场地图

第六章：北美客製化基因合成​​服务市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 北美：国家分析
    • 加拿大
    • 墨西哥

第七章：欧洲客製化基因合成​​服务市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 欧洲：国家分析
    • 英国
    • 义大利
    • 法国
    • 西班牙

第 8 章：亚太地区客製化基因合成​​服务市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 亚太地区：国家分析
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：南美洲客製化基因合成​​服务市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 南美洲：国家分析
    • 阿根廷
    • 哥伦比亚

第 10 章：中东和非洲客製化基因合成​​服务市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • MEA：国家分析
    • 沙乌地阿拉伯
    • 阿联酋

第 11 章：市场动态

  • 驱动程式
  • 挑战

第 12 章：市场趋势与发展

  • 合併与收购（如有）
  • 产品发布（如果有）
  • 最新动态

第 13 章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 顾客的力量
  • 替代产品的威胁

第 14 章：竞争格局

  • GenScript Biotech Corporation
  • Biomatik Corporation
  • Thermo Fisher Scientific Inc.
  • Integrated DNA Technologies, Inc.
  • Synbio Technologies LLC
  • Biomol GmbH
  • Eurofins Genomics Germany GmbH
  • BioCat GmbH
  • Azenta US Inc.
  • ProMab Biotechnologies, Inc.

第 15 章：策略建议

第16章 调査会社について・免责事项

简介目录
Product Code: 19087

The global Custom Gene Synthesis Service Market was valued at USD 1.54 billion in 2024 and is projected to reach USD 2.52 billion by 2030, growing at a CAGR of 8.54% during the forecast period. This market has emerged as a dynamic and rapidly evolving sector within the life sciences and biotechnology industries. Custom gene synthesis services involve the artificial creation of DNA sequences, enabling researchers and biotech companies to design and obtain custom genetic material for various applications.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 1.54 Billion
Market Size 2030USD 2.52 Billion
CAGR 2025-20308.54%
Fastest Growing SegmentCommercial
Largest MarketNorth America

The market has experienced significant growth in recent years, driven by the increasing demand for synthetic DNA constructs across fields such as gene therapy, synthetic biology, vaccine development, and genetic engineering. The rise of personalized medicine and targeted therapies is one of the key drivers. Custom-designed DNA sequences are essential for developing gene therapies aimed at treating genetic disorders and diseases at the molecular level. Additionally, the expansion of synthetic biology has created new opportunities for designing and engineering biological systems, further increasing the demand for synthetic DNA.

Technological advancements, particularly in gene synthesis methods like solid-phase synthesis, have improved the accuracy and efficiency of DNA synthesis, fueling market growth. The reduction in gene synthesis costs, coupled with a growing number of service providers, has made custom gene synthesis more accessible to researchers and organizations of all sizes.

Key Market Drivers

Increasing Demand for Personalized Medicine: Personalized medicine is a significant driver for the growth of the custom gene synthesis service market. This healthcare approach aims to tailor treatments based on an individual's genetic makeup and relies heavily on the precise design and creation of custom DNA sequences. For example, in February 2022, Integrated DNA Technologies, Inc. launched Alt-R HDR Donor Blocks, which facilitate gene editing using Homology-directed Repair (HDR) - a critical tool for developing new treatments.

Custom gene synthesis services are central to the development of personalized treatments by providing the necessary genetic material for advanced therapies. In gene therapy, custom DNA sequences are used to correct or replace faulty genes that cause genetic disorders, ensuring treatments are specific and effective while minimizing side effects. The rise of CRISPR-Cas9 technology, which depends on precisely engineered DNA sequences to target and modify genes, further boosts the demand for custom gene synthesis.

Custom gene synthesis services are also essential in developing treatments for cancer, autoimmune diseases, and rare conditions, as these therapies require the creation of DNA constructs to target the unique genetic markers of individual patients. As personalized medicine continues to gain traction, the demand for custom gene synthesis services is expected to increase significantly.

Key Market Challenges

Cost Constraints: Despite the impressive growth of the custom gene synthesis service market, cost remains a significant challenge to its widespread adoption. One of the primary cost-related challenges is the high expense associated with synthesizing long and complex DNA sequences. Although technological advancements have improved efficiency, DNA production is still relatively costly, posing a barrier for researchers, especially those working with limited budgets in academic institutions or startups. This can limit access to custom gene synthesis services, hindering the broader adoption of this technology.

Another challenge is the variability in pricing among service providers. The absence of standardized pricing models makes it difficult for customers to compare options and select the most cost-effective solutions. This lack of consistency can create confusion and uncertainty among potential users, slowing market growth. Furthermore, the cost of custom gene synthesis services impacts research budgets, limiting researchers' ability to fully utilize these services, potentially delaying research and slowing scientific progress.

Key Market Trends

Emerging Applications in Drug Discovery: Emerging applications in drug discovery are playing a critical role in driving the demand for custom gene synthesis services. The pharmaceutical industry, a significant consumer of these services, is increasingly relying on synthesized DNA constructs for gene function studies, drug target validation, and therapeutic protein production. As drug discovery becomes more complex, the need for precision and customization has risen sharply.

The CRISPR-Cas9 genome editing technology is one of the key innovations fueling the demand for custom gene synthesis. This technology enables precise gene editing, which is essential for identifying and validating potential drug targets. Custom-designed DNA constructs are vital for guiding CRISPR-Cas9 to the specific genomic locations, enabling accurate gene editing.

Additionally, the growing focus on personalized medicine within drug development is driving the demand for custom gene synthesis. Custom DNA sequences are used to create patient-specific models for drug response testing, ensuring that treatments are tailored to individual genetic profiles, which improves drug efficacy and reduces adverse effects.

In June 2023, Eurofins Genomics Blue Heron introduced its In-Vitro Transcription (IVT) Messenger RNA (mRNA) Synthesis Service. This service offers a high-quality, customizable solution for researchers involved in various fields, including molecular biology, drug discovery, vaccine development, and gene therapy.

Key Market Players

  • GenScript Biotech Corporation
  • Biomatik Corporation
  • Thermo Fisher Scientific Inc.
  • Integrated DNA Technologies, Inc.
  • Synbio Technologies LLC
  • Biomol GmbH
  • Eurofins Genomics Germany GmbH
  • BioCat GmbH
  • Azenta US Inc.
  • ProMab Biotechnologies, Inc.

Report Scope:

This report segments the Global Custom Gene Synthesis Service Market as follows, along with detailed insights on industry trends:

By Type:

  • Below 1000 bp
  • 1001 to 3000 bp
  • 3001 to 5000 bp
  • Above 5000 bp

By Application:

  • Commercial
  • Academic Research

By Region:

  • North America: United States, Canada, Mexico
  • Europe: France, United Kingdom, Italy, Germany, Spain
  • Asia-Pacific: China, India, Japan, Australia, South Korea
  • South America: Brazil, Argentina, Colombia
  • Middle East & Africa: South Africa, Saudi Arabia, UAE

Competitive Landscape: This section provides a detailed analysis of major companies operating in the Global Custom Gene Synthesis Service Market.

Available Customizations: TechSci Research offers customizations to this report to meet the specific needs of a company. Customization options include:

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Custom Gene Synthesis Service Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Below 1000 bp, 1001 to 3000 bp, 3001 to 5000 bp, above 5000 bp)
    • 5.2.2. By Application (Commercial, Academic Research)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Custom Gene Synthesis Service Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Application
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Custom Gene Synthesis Service Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Application
    • 6.3.2. Canada Custom Gene Synthesis Service Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Application
    • 6.3.3. Mexico Custom Gene Synthesis Service Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Application

7. Europe Custom Gene Synthesis Service Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Application
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Custom Gene Synthesis Service Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Application
    • 7.3.2. United Kingdom Custom Gene Synthesis Service Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Application
    • 7.3.3. Italy Custom Gene Synthesis Service Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Application
    • 7.3.4. France Custom Gene Synthesis Service Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Application
    • 7.3.5. Spain Custom Gene Synthesis Service Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Application

8. Asia-Pacific Custom Gene Synthesis Service Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Application
    • 8.2.3. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Custom Gene Synthesis Service Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Application
    • 8.3.2. India Custom Gene Synthesis Service Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Application
    • 8.3.3. Japan Custom Gene Synthesis Service Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Application
    • 8.3.4. South Korea Custom Gene Synthesis Service Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Application
    • 8.3.5. Australia Custom Gene Synthesis Service Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Application

9. South America Custom Gene Synthesis Service Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Application
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Custom Gene Synthesis Service Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Application
    • 9.3.2. Argentina Custom Gene Synthesis Service Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Application
    • 9.3.3. Colombia Custom Gene Synthesis Service Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Application

10. Middle East and Africa Custom Gene Synthesis Service Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Application
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Custom Gene Synthesis Service Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Application
    • 10.3.2. Saudi Arabia Custom Gene Synthesis Service Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Application
    • 10.3.3. UAE Custom Gene Synthesis Service Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. GenScript Biotech Corporation
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Products & Services
    • 14.1.4. Financials (As Reported)
    • 14.1.5. Recent Developments
    • 14.1.6. Key Personnel Details
    • 14.1.7. SWOT Analysis
  • 14.2. Biomatik Corporation
  • 14.3. Thermo Fisher Scientific Inc.
  • 14.4. Integrated DNA Technologies, Inc.
  • 14.5. Synbio Technologies LLC
  • 14.6. Biomol GmbH
  • 14.7. Eurofins Genomics Germany GmbH
  • 14.8. BioCat GmbH
  • 14.9. Azenta US Inc.
  • 14.10. ProMab Biotechnologies, Inc.

15. Strategic Recommendations

16. About Us & Disclaimer